Reuters logo
BRIEF-Lipocine completes enrollment in the LPCN 1021 fixed dose clinical trials
April 24, 2017 / 12:14 PM / 6 months ago

BRIEF-Lipocine completes enrollment in the LPCN 1021 fixed dose clinical trials

April 24 (Reuters) - Lipocine Inc

* Lipocine completes enrollment in the LPCN 1021 fixed dose clinical trials

* To announce top-line results from LPCN 1021 fixed dose clinical trials in June 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below